Senior Health - SeniorCenters.com

Senior Health

Senior Health
Prostate / Prostate Cancer News From Medical News Today
Latest Prostate / Prostate Cancer News From Medical News Today.
Amgen Announces Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer Amgen (NASDAQ:AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer. Impact Of Surgical Volume On The Rate Of Lymph Node Metastases In Patients Undergoing Radical Prostatectomy UroToday.com - In this online publication by Dr. Alberto Briganti and associates that appears in European Urology, the authors hypothesized that surgical volume (SV) is related to the detection rate of lymph node invasion (LNI) in a single-institution cohort of men treated with radical prostatectomy (RP) and extended pelvic lymph node dissection (ePLND). Association Between Serum Prostate-Specific Antigen Level, Liver Function Tests And Lipid Profile In Healthy Men UroToday.com - In the online version of the BJU International, a group of Korean investigators has reported on the impact of liver function and lipid parameters on PSA levels. The liver is involved in eliminating serum PSA, but the kidneys and lungs are not. Free PSA is eliminated by the kidneys, but due to its molecular size, PSA bound to larger proteins is cleared through the liver. Furthermore, the lipid profile can affect serum PSA levels through the metabolism of serum testosterone. Dendreon Initiates Phase 2 Trial Of PROVENGE In Patients With Localized Prostate Cancer Prior To Surgery Dendreon Corporation (Nasdaq: DNDN) announced that the Company has initiated a Phase 2 trial of PROVENGE(R) (sipuleucel-T), Dendreon's investigational active cellular immunotherapy for the treatment of prostate cancer, in men with localized prostate cancer who are scheduled to undergo a radical prostatectomy. Possible Link Found Between X-rays And Prostate Cancer Researchers at The University of Nottingham have shown an association between certain past diagnostic radiation procedures and an increased risk of young-onset prostate cancer - a rare form of prostate cancer which affects about 10 per cent of all men diagnosed with the disease. Bone Drug Reduces Fractures In Men Having Hormone Therapy For Prostate Cancer Drugmaker Amgen Inc announced yesterday, Monday, that a large trial of its bone drug denosumab increased bone density and cut fractures in men with non-metastatic prostate cancer who were having hormone blocking therapy. A side effect of androgen deprivation therapy (ADT), which stops the male hormones feeding the cancer, is weaker bones and increased risk of fracture. Four New Research Grants Awarded To Help Fight 'Taboo' Disease, Prostate Cancer, UK The Prostate Cancer Charity is supporting four new research projects across the UK. The projects, totaling over £500,000, aim to increase scientific understanding of prostate cancer and benefit current and future generations of men affected by the disease and their partners and families. Positive Top-Line Results For Denosumab Treatment Of Bone Loss In Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy Amgen (NASDAQ: AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer. Theragenics Corporation(R) Engages Men In A National Debate On Prostate Cancer Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate. Fertility Issues In Patients With Prostate Cancer UroToday.com - With PSA screening, men are being diagnosed with prostate cancer (CaP) at younger ages. In the online issue of the BJU International, Dr. Steinsvik and colleagues address the issues of fertility as related to prostate cancer therapies. In Norway, the percentage of patients aged

[ Back ]